These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6143287)

  • 1. Presynaptic dopaminergic control of high affinity glutamate uptake in the striatum.
    Nieoullon A; Kerkerian L; Dusticier N
    Neurosci Lett; 1983 Dec; 43(2-3):191-6. PubMed ID: 6143287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum.
    Kerkerian L; Dusticier N; Nieoullon A
    J Neurochem; 1987 Apr; 48(4):1301-6. PubMed ID: 2880932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons.
    Kerkerian L; Nieoullon A
    Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic dopaminergic modulation of cortical input to the striatum.
    Kornhuber J; Kornhuber ME
    Life Sci; 1986 Aug; 39(8):699-74. PubMed ID: 2874471
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
    Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J
    Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of dopamine on high affinity glutamate uptake from rat striatum.
    Nieoullon A; Kerkerian L; Dusticier N
    Life Sci; 1982 Apr; 30(14):1165-72. PubMed ID: 6123930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms.
    Garside S; Furtado JC; Mazurek MF
    Neuroscience; 1996 Dec; 75(4):1065-74. PubMed ID: 8938742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of presynaptic dopamine receptors in regulation of the glutamatergic neurotransmission in rat neostriatum.
    Godukhin OV; Zharikova AD; Budantsev AYu
    Neuroscience; 1984 Jun; 12(2):377-83. PubMed ID: 6146947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a micromethod to study the Na+-independent L-[3H]glutamic acid binding to rat striatal membranes. II. Effects of selective striatal lesions and deafferentations.
    Errami M; Nieoullon A
    Brain Res; 1986 Feb; 366(1-2):178-86. PubMed ID: 2870763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation.
    Garcia-Munoz M; Young SJ; Groves PM
    Brain Res; 1991 Jun; 551(1-2):195-206. PubMed ID: 1913151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine.
    Chéramy A; Barbeito L; Godeheu G; Desce JM; Pittaluga A; Galli T; Artaud F; Glowinski J
    J Neural Transm Suppl; 1990; 29():183-93. PubMed ID: 1972733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Gale K; Casu M
    Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827
    [No Abstract]   [Full Text] [Related]  

  • 14. Cortical modulation of striatal function.
    Scatton B; Worms P; Lloyd KG; Bartholini G
    Brain Res; 1982 Jan; 232(2):331-43. PubMed ID: 6200179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum.
    Kötter R
    Prog Neurobiol; 1994 Oct; 44(2):163-96. PubMed ID: 7831476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenoceptors are not involved in the regulation of striatal glutamate release: comparison to dopaminergic inhibition.
    Harsing LG; Vizi ES
    J Neurosci Res; 1991 Mar; 28(3):376-81. PubMed ID: 1677428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic regulation of dopaminergic transmission in the striatum.
    Glowinski J; Chéramy A; Romo R; Barbeito L
    Cell Mol Neurobiol; 1988 Mar; 8(1):7-17. PubMed ID: 2900072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of rat pallidum cells to cortex stimulation and effects of altered dopaminergic activity.
    Toan DL; Schultz W
    Neuroscience; 1985 Jul; 15(3):683-94. PubMed ID: 2866467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of dopamine and its receptors in generation of choreic movements.
    Kanazawa I; Murata M; Kimura M
    Adv Neurol; 1993; 60():107-12. PubMed ID: 8093572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.